People Briefs: InVivo Therapeutics CEO Resigns; CVPath Institute, Harvard Bioscience Appoint New CEOs
This article was originally published in The Gray Sheet
InVivo Therapeutics Holdings Corp. chairman and CEO resigns. CVPath Institute and Harvard Bioscience get new CEOs. Cook Medical appoints VP to lead its aortic intervention clinical division. Sunshine Heart names chief medical officer.
You may also be interested in...
Edwards Lifesciences chief financial officer to retire. Trice Orthopedics raises $3 million, names president. More people briefs
Merit snaps up Thomas Medical. Halma buys MicroSurgical Technology. Sanofi settles Hyalgan charges. More news briefs.
Firm preps for U.S. pivotal trial and European market launch in the third quarter for its minimally invasive, extra-aortic balloon counter-pulsation system for moderate to severe heart failure.